2026 DHA CPC: A Partial Agonist with Full Effect: Understanding the Complexity of Buprenorphine

October 27, 2026

For more information about this activity, please contact Dawn Soulati at [email protected].

Target Audience

This activity provides continuing education for pharmacists and pharmacy technicians across the Military Health System (MHS). A certificate of attendance is available for other attendees.

Learning Objectives

  1. Describe the unique pharmacology of buprenorphine.
  2. Formulate a plan to convert a patient from a pure mu opioid to buprenorphine.
  3. Summarize patient specific recommendations for the use of buprenorphine in special populations.

Course summary

Available credit: 
  • 1.00 ACPE-Pharm

    UAN:
    No valid paper/electronic statement of credit will be offered. DHA J-7 CEPO is accredited by the American Council for Pharmacy Education (ACPE) to provide continuing education for Pharmacists. This knowledge-based activity will provide a maximum of 1.00 contact hours of pharmacy continuing education credit. Participant CE records will be electronically communicated to CPE Monitor. There is no cost to participate in this activity.

  • 1.00 ACPE-Tech

    UAN:
    No valid paper/electronic statement of credit will be offered. DHA J-7 CEPO is accredited by the American Council for Pharmacy Education (ACPE) to provide continuing education for Pharmacy Technicians. This knowledge-based activity will provide a maximum of 1.00 contact hours of pharmacy continuing education credit. Participant CE records will be electronically communicated to CPE Monitor. There is no cost to participate in this activity.

  • 1.00 Attendance
Course opens: 
10/19/2026
Course expires: 
11/12/2026
Event starts: 
10/27/2026 - 12:00pm EDT
Event ends: 
10/27/2026 - 1:00pm EDT
Part of: 
2026 DHA POD Clinical Pharmacy Course
Add to calendar: 

Jessica Hagel, Pharm.D.  Presenter has no relevant financial or non-financial relationship(s) relating to the course content or with ineligible companies to disclose.

Disclosures: DHA J-7 staff, planners, authors, faculty, and content reviewers for this educational activity have no relevant financial or non-financial relationship(s) relating to the course content or with ineligible companies to disclose. No commercial support was provided for this activity.

Available Credit

  • 1.00 ACPE-Pharm

    UAN:
    No valid paper/electronic statement of credit will be offered. DHA J-7 CEPO is accredited by the American Council for Pharmacy Education (ACPE) to provide continuing education for Pharmacists. This knowledge-based activity will provide a maximum of 1.00 contact hours of pharmacy continuing education credit. Participant CE records will be electronically communicated to CPE Monitor. There is no cost to participate in this activity.

  • 1.00 ACPE-Tech

    UAN:
    No valid paper/electronic statement of credit will be offered. DHA J-7 CEPO is accredited by the American Council for Pharmacy Education (ACPE) to provide continuing education for Pharmacy Technicians. This knowledge-based activity will provide a maximum of 1.00 contact hours of pharmacy continuing education credit. Participant CE records will be electronically communicated to CPE Monitor. There is no cost to participate in this activity.

  • 1.00 Attendance
Please login or create an account to take this course.

 
Requirements:  CE/CME certificates are awarded to MHS participants who fully complete the activity, successfully submit the evaluation survey, and pass the posttest with a minimum score of 80% unless noted otherwise. The deadline to claim credit is Nov 12, 2026.

Access Code/Accommodations: Some activities require an access code to register or claim CE/CME credit. For inquiries regarding the access code or accommodations, please email Soulati, Teresa D (Dawn) CIV DHA 88TH MDG (USA) at [email protected]. 

For technical support, email [email protected].

 

There is no cost to participate in this activity.
 

Required Hardware/software